Trial Outcomes & Findings for Third Trimester Screening of Fetal Growth Restriction (NCT NCT05787054)
NCT ID: NCT05787054
Last Updated: 2025-04-30
Results Overview
Rate of newborns with a Birth Weight \<10 th centile according to International Prescriptive Charts who were prenatally identified
COMPLETED
NA
813 participants
at birth
2025-04-30
Participant Flow
Participant milestones
| Measure |
Single Scan
Single scan at 28-32 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
Longitudinal Scan
Longitudinal scan at 28-32 AND 35-37 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
|---|---|---|
|
Overall Study
STARTED
|
407
|
406
|
|
Overall Study
COMPLETED
|
396
|
394
|
|
Overall Study
NOT COMPLETED
|
11
|
12
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Third Trimester Screening of Fetal Growth Restriction
Baseline characteristics by cohort
| Measure |
Single Scan
n=396 Participants
Single scan at 28-32 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
Longitudinal Scan
n=394 Participants
Longitudinal scan at 28-32 AND 35-37 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
Total
n=790 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
30.7 years
n=99 Participants
|
30.7 years
n=107 Participants
|
30.7 years
n=206 Participants
|
|
Sex: Female, Male
Female
|
396 Participants
n=99 Participants
|
394 Participants
n=107 Participants
|
790 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
4 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
9 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
390 Participants
n=99 Participants
|
389 Participants
n=107 Participants
|
779 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
2 Participants
n=206 Participants
|
|
Region of Enrollment
Italy
|
396 participants
n=99 Participants
|
394 participants
n=107 Participants
|
790 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: at birthPopulation: sensibility of two screening protocols
Rate of newborns with a Birth Weight \<10 th centile according to International Prescriptive Charts who were prenatally identified
Outcome measures
| Measure |
Single Scan
n=396 Participants
Single scan at 28-32 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
Longitudinal Scan
n=394 Participants
Longitudinal scan at 28-32 AND 35-37 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
|---|---|---|
|
Rate of Small for Gestational Age at Birth Identified Antenatally
|
28 Participants
|
46 Participants
|
SECONDARY outcome
Timeframe: at birthPopulation: Odds Ratio for Cesarean section
Rate of patients undergoing C section rather than spontaneous vaginal birth
Outcome measures
| Measure |
Single Scan
n=396 Participants
Single scan at 28-32 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
Longitudinal Scan
n=394 Participants
Longitudinal scan at 28-32 AND 35-37 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
|---|---|---|
|
Rate of Cesarean Section in the Two Groups
|
84 Participants
|
76 Participants
|
SECONDARY outcome
Timeframe: up to 40 days after birthPopulation: rate of neonatal admission into intensive care unit
rate of admission into neonatal intensive care unit
Outcome measures
| Measure |
Single Scan
n=396 Participants
Single scan at 28-32 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
Longitudinal Scan
n=394 Participants
Longitudinal scan at 28-32 AND 35-37 weeks
Third trimester ultrasound: Single scan versus Longitudinal scan
|
|---|---|---|
|
Rate of Adverse Outcomes
|
15 Participants
|
4 Participants
|
Adverse Events
Single Scan
Longitudinal Scan
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr Alessandra Familiari
Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place